Young EAP now has official representatives to support the European Board of Paediatrics (EBP) and EAP advocacy activities, especially in areas where the voice of trainees is needed. In addition, several Young EAP members have submitted their candidatures for Young EAP Core Group positions.
The elections will take place during the monthly Young EAP meeting on March 27, 2018.
Tommaso Alterio (Italy) is the Young EAP representative for the EBP. He will assist Professor Robert Ross Russell (EBP Chair) with the development of the European Exam and the revision of the European Core Curriculum. Tommaso will be supported by the Young EAP Task Force for the EBP. Tommaso is a member of the Osservatorio Nazionale Specializzandi Pediatria (ONSP) and currently works as a fellow in Paediatric Gastro-enterology (IBD) at the Bambino Gesù Children’s Hospital in Rome. For Tommaso, Young EAP is an opportunity and an ongoing project where young doctors from all over Europe can find a place to work together for a better future in paediatric training and care. In his new role, he hopes to make this possible by shortening the distance between residents and Young EAP.
Sian Copley (United Kingdom) is the Young EAP representative for Advocacy. She will assist Professor Ana Neves (EAP Vice President) in advocacy activities. Sian will be assisted by Veronica Said Pullicino (Malta) and Andreas Trobisch (Austria). Sian is a member of the Royal College of Paediatrics and Child Health (RCPCH) Trainees’ Committee and currently works as a third-year resident at the Health Education North East in the UK. In her new role, she looks forward to representing trainees’ views on issues related to child health across Europe, raise awareness of current issues and promote this within paediatric training, as well as to advocate for children’s rights to health.
Franck Zekre (France) and Ivan Bambir (Croatia) are candidates for the position of Vice Chair. Lenneke Schrier (The Netherlands) is the candidate for Chair.
Franck Zekre is the representative for International Affairs of the Association des Junior en Pediatrie (AJP). He is in his third semester at Saint Etienne’s in France. Being born in the Ivory Coast, he recognises the important opportunity of being trained in France, and he intends to use all he has learned for the benefit of others. He feels that Young EAP allows young paediatricians to exchange ideas in order to improve training. He is looking forward to bringing his energy to improve these exchanges of ideas between members.
Ivan Bambir is a member of the Resident Section of the Croatian Paediatric Society and a fifth-year resident at the University Hospital Centre Zagreb in Croatia. He firmly believes that the beginning of everything, including Young EAP, is a defining moment in the development of that. He believes his previous experience in setting up the Youth Leadership NGO can contribute to give Young EAP a stable long-term path.
Lenneke Schrier is the European Junior Doctor representative within the EAP and a fourth-year resident at the Leiden University Medical Center in The Netherlands. Since medical school, she has asked herself what kind of paediatricians children need, both now and in the future. She offers her previous experience within the EAP and other international settings, like the International Federation of Medical Students’ Associations and the World Health Organisation, to articulate Young EAP’s strategic vision to others and translate these in actions in such a way that, in five years, it will be hard to imagine child health without Young EAP.
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
